Home » Topics » BioWorld Science

BioWorld Science
RSS

Integral BioSciences discloses IDH1 mutant inhibitors

July 23, 2020

Chinese investigators patent P2X3 receptor antagonists

July 23, 2020

SPV Therapeutics synthesizes new CDK inhibitors

July 23, 2020

CSF-1R as novel therapeutic target in 4T1 xenografts

July 23, 2020

RO-7297089 demonstrates target engagement and safety in models of MM

July 23, 2020

SOCS3 as a new therapeutic target in breast cancer

July 23, 2020

Phase Ib/II study of margetuximab + pembrolizumab in HER2-positive gastroesophageal adenocarcinoma

July 23, 2020

Characterization of real-time CAH degradation under pH environment of GI tract using microrheology

July 23, 2020

Potent dual orexin OX1/2 receptor antagonist with improved PK profile for insomnia treatment

July 23, 2020

TTX-3360 selected as Triplet's first clinical candidate for repeat expansion disorders

July 23, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...